Literature DB >> 1569102

Primary structure of the human heparan sulfate proteoglycan from basement membrane (HSPG2/perlecan). A chimeric molecule with multiple domains homologous to the low density lipoprotein receptor, laminin, neural cell adhesion molecules, and epidermal growth factor.

A D Murdoch1, G R Dodge, I Cohen, R S Tuan, R V Iozzo.   

Abstract

We have determined the complete nucleotide and deduced amino acid sequence of the major protein core of the human heparan sulfate proteoglycan HSPG2/perlecan of basement membranes. Eighteen overlapping cDNA clones comprise 14.35 kilobase pairs (kb) of contiguous sequence with an open reading frame of 13.2 kb. The mature protein core, without the signal peptide of 21 amino acids, has a M(r) of 466,564. This large protein is composed of multiple modules homologous to the receptor of low density lipoprotein, laminin, neural cell adhesion molecules, and epidermal growth factor. Domain I, near the amino terminus, appears unique for the proteoglycan since it shares no significant homology with any other proteins. It contains three Ser-Gly-Asp sequences that could act as attachment sites for heparan sulfate glycosaminoglycans. Domain II is highly homologous to the LDL receptor and contains four repeats with perfect conservation of all 6 consecutive cysteines. Next is domain III which shares homology to the short arm of laminin A chain and contains four cysteine-rich regions intercalated among three globular domains. Domain IV, the largest module with greater than 2000 residues, contains 21 repeats of the immunoglobulin type as found in neural cell adhesion molecule. Near the beginning of this domain, there is a stretch of 29 hydrophobic amino acids which could allow the molecule to interact with the plasma membrane. Domain V, similar to the carboxyl-terminal globular G-domain of laminin A and to the related protein merosin, contains three globular regions and four EGF-like repeats. In situ hybridization and immunoenzymatic studies show a close association of this gene product with a variety of cells involved in the assembly of basement membranes, in addition to being localized within the stromal elements of various connective tissues. Our studies show that this proteoglycan is present in all vascularized tissues and suggest that this unique molecule has evolved from the utilization of modular structures with adhesive and growth regulatory properties.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1569102

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  83 in total

1.  Comparative spatial and temporal localisation of perlecan, aggrecan and type I, II and IV collagen in the ovine meniscus: an ageing study.

Authors:  James Melrose; Susan Smith; Martin Cake; Richard Read; John Whitelock
Journal:  Histochem Cell Biol       Date:  2005-10-28       Impact factor: 4.304

Review 2.  Contribution of proteoglycans towards the integrated functions of renal glomerular capillaries: a historical perspective.

Authors:  Yashpal S Kanwar; Farhad R Danesh; Sumant S Chugh
Journal:  Am J Pathol       Date:  2007-07       Impact factor: 4.307

Review 3.  Effects of mechanical ventilation on the extracellular matrix.

Authors:  Paolo Pelosi; Patricia R Rocco
Journal:  Intensive Care Med       Date:  2008-02-09       Impact factor: 17.440

4.  Vascular growth factor binding kinetics to the endothelial cell basement membrane, with a kinetics-based correction for substrate binding.

Authors:  Alisa Morss Clyne; Elazer R Edelman
Journal:  Cytotechnology       Date:  2009-07-29       Impact factor: 2.058

5.  Mutations in the unc-52 gene responsible for body wall muscle defects in adult Caenorhabditis elegans are located in alternatively spliced exons.

Authors:  T M Rogalski; E J Gilchrist; G P Mullen; D G Moerman
Journal:  Genetics       Date:  1995-01       Impact factor: 4.562

6.  A novel peptide sequence in perlecan domain IV supports cell adhesion, spreading and FAK activation.

Authors:  Mary C Farach-Carson; Anissa J Brown; Megan Lynam; Jeffrey B Safran; Daniel D Carson
Journal:  Matrix Biol       Date:  2007-10-10       Impact factor: 11.583

Review 7.  Role of perlecan in skeletal development and diseases.

Authors:  John Hassell; Yoshihiko Yamada; Eri Arikawa-Hirasawa
Journal:  Glycoconj J       Date:  2002 May-Jun       Impact factor: 2.916

8.  The proteoglycan perlecan is expressed in the erythroleukemia cell line K562 and is upregulated by sodium butyrate and phorbol ester.

Authors:  S Grässel; I R Cohen; A D Murdoch; I Eichstetter; R V Iozzo
Journal:  Mol Cell Biochem       Date:  1995-04-12       Impact factor: 3.396

9.  Glomerular filtration is normal in the absence of both agrin and perlecan-heparan sulfate from the glomerular basement membrane.

Authors:  Seth Goldberg; Scott J Harvey; Jeanette Cunningham; Karl Tryggvason; Jeffrey H Miner
Journal:  Nephrol Dial Transplant       Date:  2009-01-14       Impact factor: 5.992

10.  Smooth muscle cell expression of extracellular matrix genes after arterial injury.

Authors:  S T Nikkari; H T Järveläinen; T N Wight; M Ferguson; A W Clowes
Journal:  Am J Pathol       Date:  1994-06       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.